Clinical Trials Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy 12 Jan 2021
BeiGene doses first patient in Phase lll trial of tislelizumab BeiGene has dosed the first patient in a Phase lll clinical trial of tislelizumab in... 25th July 2018